Immediate Utility of Two Approved Agents to Target Both the Metabolic Mevalonate Pathway and Its Restorative Feedback Loop

Cancer Research - United States
doi 10.1158/0008-5472.can-14-0130
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Metabolic Pathway and Its Relationship to the Biological Activity of Some Tuberculostatic and Leprostatic Agents

Leprosy Review
DermatologyMedicineInfectious Diseases
1964English

Drug Repositioning of Mevalonate Pathway Inhibitors as Antitumor Agents for Ovarian Cancer

Oncotarget
Oncology
2017English

Cyanobacterial Non-Mevalonate Pathway

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

P53 Represses the Mevalonate Pathway to Mediate Tumor Suppression

Cell
BiochemistryGeneticsMolecular Biology
2019English

YAP Activates the Hippo Pathway in a Negative Feedback Loop

Cell Research
Cell BiologyMolecular Biology
2015English

Antimicrobial Agents for Myocarditis: Target the Pathway, Not the Pathogen

Heart
Cardiovascular MedicineCardiology
2009English

Widespread Occurrence of Both Metabolic and Target-Site Herbicide Resistance Mechanisms inLolium Rigidumpopulations

Pest Management Science
MedicineInsect ScienceAgronomyCrop Science
2015English

Restorative Yoga and Metabolic Risk Factors: The Practicing Restorative Yoga vs. Stretching for the Metabolic Syndrome (PRYSMS) Randomized Trial

Journal of Diabetes and its Complications
Internal MedicineEndocrinologyMetabolismDiabetes
2014English

New Antimicrobial Agents Approved by the U.S. Food and Drug Administration in 1997 and New Indications for Previously Approved Agents

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy